Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease is a research paper published in Clinical and Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAMS NIH HHS
Grant: R21 AR080972
FDA HHS
Grant: R01 FD007478
National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)
Grant: R21AR080972-01
National Institutes of Health
Grant: 5R21AR080972-02
Antisense oligonucleotide treatment for Pompe disease
The Helen Walker Award, Acid Maltase Deficiency Association (AMDA)
The Council on Research, Computing, and Libraries (CORCL) at the University of California, Irvine
The Helen Walker Award, Acid Maltase Deficiency Association (AMDA)
The Council on Research, Computing, and Libraries (CORCL) at the University of California, Irvine
FWCI
0.79
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals